AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Core Viewpoint - The proposed sale of Akoya Biosciences, Inc. to Quanterix Corporation is under investigation to assess whether the transaction adequately values Akoya and the process leading to this valuation [1]. Group 1: Transaction Details - Under the terms of the proposed transaction, Akoya shareholders will receive 0.318 shares of Quanterix for each share of Akoya they own [1]. Group 2: Legal Investigation - Kahn Swick & Foti, LLC is investigating the proposed sale to determine if the consideration is adequate or if it undervalues Akoya [1]. - The firm is inviting shareholders who believe the transaction undervalues the company to discuss their legal rights regarding the proposed sale [2].